A carregar...
Using Molecular Biology to Develop Drugs for Renal Cell Carcinoma
BACKGROUND: Renal cell carcinoma is a disease marked by a unique biology which has governed it’s long history of poor response to conventional cancer treatments. The discovery of the signaling pathway activated as a result of inappropriate constitutive activation of the hypoxia inducible factors (HI...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2906134/ https://ncbi.nlm.nih.gov/pubmed/20648240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17460441.3.3.311 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|